Your search returned 15 results.

Results
	1.	Targeted Therapies in Combination With Immune Therapies for the Treatment of Metastatic Melanoma. MedStar authors: Khan, Shaheer PMID: 28114256 Year: 2017 Citation: Cancer Journal. 23(1):59-62, 2017 Jan/Feb Institution: MedStar Washington Hospital Center Department: Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Christiansen SA, Gibney GT, Khan S DOI: https://dx.doi.org/10.1097/PPO.0000000000000245 Add to cart (remove)
	2.	Report from Session III of the Second International Colloquium on Cardio-oncology: Cardio-oncological management of patients. [Review] MedStar authors: Barac, Ana PMID: 31784042 Year: 2019 Citation: Seminars in Oncology. 46(6):408-413, 2019 12. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Barac A, Cardinale DM, Khandheria BK, Lenihan D, Minotti G, Torbicki A DOI: https://dx.doi.org/10.1053/j.seminoncol.2019.11.002 Add to cart (remove)
	3.	Radioiodine refractory differentiated thyroid cancer. [Review] MedStar authors: Van Nostrand, Douglas PMID: 29650270 Year: 2018 Citation: Critical Reviews in Oncology-Hematology. 125:111-120, 2018 May. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Chen L, Cheng L, Jin Y, Liu M, Van Nostrand D DOI: https://dx.doi.org/10.1016/j.critrevonc.2018.03.012 Add to cart (remove)
	4.	Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors. [Review] MedStar authors: Barac, Ana PMID: 34110908 Year: 2021 Citation: Circulation Research. 128(12):1973-1987, 2021 06 11. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Barac A, Beckman JA, Fleming MR, Jackson KD, Moslehi JJ, Xiao L DOI: https://dx.doi.org/10.1161/CIRCRESAHA.121.318259 Add to cart (remove)
	5.	Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors: Swain, Sandra M PMID: 23602601 Year: 2013 Citation: Lancet Oncology. 14(6):461-71, 2013 May. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM DOI: http://dx.doi.org/10.1016/S1470-2045(13)70130-X Add to cart (remove)
	6.	Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies. [Review] MedStar authors: Agunbiade, Tolulope A Barac, Ana Zaghlol, Raja PMID: 31988685 Year: 2019 Citation: Methodist DeBakey cardiovascular journal. 15(4):250-257, 2019 Oct-Dec. Institution: MedStar Heart & Vascular Institutena MedStar Union Memorial Hospital MedStar Washington Hospital Center Department: Cardio-Oncology Medicine/Internal Medicine Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Agunbiade TA, Barac A, Zaghlol RY DOI: https://dx.doi.org/10.14797/mdcj-15-4-250 Add to cart (remove)
	7.	A case of checkpoint inhibitor-induced celiac disease. MedStar authors: Alsaadi, Dana PMID: 31383006 Year: 2019 Citation: Journal for Immunotherapy of Cancer. 7(1):203, 2019 08 05. Institution: MedStar Washington Hospital Center Department: Medicine/Internal Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Alsaadi D, Atkins MB, Charabaty A, Shah NJ DOI: https://dx.doi.org/10.1186/s40425-019-0694-x Add to cart (remove)
	8.	Kinase inhibitors and monoclonal antibodies in oncology: clinical implications. [Review] MedStar authors: Groninger, Hunter PMID: 26718105 Year: 2016 Citation: Nature Reviews Clinical Oncology. 13(4):209-27, 2016 Apr. Institution: MedStar Washington Hospital Center Department: Medicine/Palliative Care Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Gharwan H, Groninger H DOI: http://dx.doi.org/10.1038/nrclinonc.2015.213 Add to cart (remove)
	9.	Salutary Response to Targeted Therapy in Anaplastic Thyroid Cancer. MedStar authors: Burman, Kenneth D PMID: 31766881 Year: 2019 Citation: Journal of Investigative Medicine High Impact Case Reports. 7:2324709619890942, 2019 Jan-Dec. Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medline publication type: Journal Article Form of publication: Journal Article All authors: Burman KD, Fazeli S, Khosla SG, Maxwell JH, Nylen ES, Paal E DOI: https://dx.doi.org/10.1177/2324709619890942 Add to cart (remove)
	10.	Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?. [Review] MedStar authors: Desai, Sanjal Kim, Chul Veytsman, Irina PMID: 31410582 Year: 2019 Citation: Current Oncology Reports. 21(9):84, 2019 08 13. Institution: Washington Cancer Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Desai S, Kim C, Veytsman I DOI: https://dx.doi.org/10.1007/s11912-019-0835-x Add to cart (remove)
	11.	Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease. MedStar authors: Epstein, Stephen E PMID: 28869590 Year: 2017 Citation: Nature Genetics. 49(10):1450-1457, 2017 Oct Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Abbas S, Ahmed N, Alam DS, Anand S, Asma S, Assimes TL, Benn M, Bottinger EP, Butterworth AS, Chambers JC, CHD Exome+ Consortium, Chen P, Chen YI, Chowdhury R, Chung RH, Damrauer S, Danesh J, Di Angelantonio E, EPIC-CVD Consortium, EPIC-Interact Consortium, Epstein S, Frikke-Schmidt R, Frossard P, Guo X, Howson JMM, Hsiung CA, Hsu CC, Hung YJ, Imamura M, Imran A, Iqbal W, Jabeen S, Juang JJ, Jukema JW, Kadowaki T, Kamstrup PR, Kooner JS, Kuo JZ, Lee IT, Lee JJ, Lee WJ, Liang KW, Loos RJF, Lu Y, Maeda S, Majeed F, Malik U, Mallick NH, Mehmood K, Mehra N, Melander O, Memon A, Memon FU, Michigan Biobank, Nielsen SF, Nordestgaard BG, Orho-Melander M, Pare G, Qamar N, Quertermous T, Qureshi IH, Rader DJ, Ralhan S, Rasheed A, Rasheed SZ, Reilly M, Ripatti S, Rizvi SNH, Rotter JI, Saghir T, Saleheen D, Salomaa V, Sanghera DK, Sapkota BR, Sattar N, Shah N, Sheu WH, Small A, Smit R, Surendran P, Tai ES, Tanveer-Us-Salam, Taylor KD, Teo YY, Tikkanen E, Trindade K, Tybjaerg-Hansen A, Voight BF, Wang TD, Yamauch T, Yaqoob Z, Young R, Zhang W, Zhao W DOI: https://dx.doi.org/10.1038/ng.3943 Add to cart (remove)
	12.	Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors: Asch, Federico M Barac, Ana Cunningham, A Gallagher, Christopher Hofmeyer, Mark Srichai, M B Swain, Sandra M PMID: 30852761 Year: 2019 Citation: Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun. Institution: MedStar Health MedStar Health Research Institute MedStar Heart & Vascular Institute Washington Cancer Institute Department: Associate Dean for Research Development Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF DOI: https://dx.doi.org/10.1007/s10549-019-05191-2 Add to cart (remove)
	13.	SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors: Asch, Federico M Barac, Ana Lynce, Filipa Swain, Sandra M PMID: 28314836 Year: 2017 Citation: Oncologist. 22(5):518-525, 2017 May Institution: MedStar Heart & Vascular Institute Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT DOI: https://dx.doi.org/10.1634/theoncologist.2016-0412 Add to cart (remove)
	14.	Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors: Swain, Sandra M PMID: 24095300 Year: 2013 Citation: Lancet Oncology. 14(12):1183-92, 2013 Nov. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N DOI: http://dx.doi.org/10.1016/S1470-2045(13)70411-X Add to cart (remove)
	15.	Glucose-deprivation increases thyroid cancer cells sensitivity to metformin. MedStar authors: Bikas, Athanasios Burman, Kenneth D Klubo-Gwiezdzinska, Joanna Wartofsky, Leonard PMID: 26362676 Year: 2015 Citation: Endocrine-Related Cancer. 22(6):919-32, 2015 Dec. Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medline publication type: Journal Article Research Support, U.S. Gov't, Non-P.H.S. Form of publication: Journal Article All authors: Bikas A, Boyle L, Burman KD, Costello J Jr, Hoperia V, Jensen K, Klubo-Gwiezdzinska J, Larin O, McDaniel D, Patel A, Vasko V, Wartofsky L DOI: http://dx.doi.org/10.1530/ERC-15-0402 Add to cart (remove)

Powered by Koha